A股收評：滬指連跌5日，創業板指漲1.64%，抱團股超跌反彈，白酒板塊集體走高
3月10日，受外圍資本市場提振的影響，A股三大指數大幅高開，隨後兩市出現分化，截至收盤，滬指連跌五日，縮量收跌0.05%報3357點；深成指漲0.65%，報13563點；創業板指漲1.64%，報2676點。個股普跌，漲幅超9%個股僅40餘家，市場賺錢效應較差。
盤面上，超跌抱團股集體反彈，山西汾酒、藥明康德等大漲；白酒、鋰電池、煤炭、碳中和、醫療等概念漲幅居前；油氣採掘板塊領跌，惠博普跌停；港口航運股集體下跌，渤海輪渡、中谷物流跌逾6%。染料概念大跌，浙江龍盛收跌4.4%；網絡遊戲、雲計算、數字貨幣等概念表現低迷。
具體來看，白酒板塊全天強勢，山西汾酒因業績超預期而強勢漲停，金種子酒、青青稞酒大漲7%，ST捨得、酒鬼酒、瀘州老窖、五糧液漲逾4%，白酒龍頭貴州茅台收漲1.7%，老白乾酒、金徽酒等跟漲。
（來源：wind）
煤炭概念漲幅居前，陝西黑貓、雲煤能源、開灤股份等封板；大有能源、山西焦化漲逾8%；安源煤業、昊華能源、淮北礦業漲超3%。
（來源：wind）
動力電池板塊集體反彈，恩捷股份、翔豐華、億緯鋰能、天賜材料漲超5%；寧德時代、比亞迪、當升科技上漲3%。除了隔夜美股大反彈的帶動影響，在美上市的中國造車新勢力蔚來、理想、小鵬被報道稱計劃最早於今年在港股上市，一定程度上增強了市場對新能源車的信心。
（來源：wind）
前期跌幅慘烈的醫藥生物板塊亦開啟反彈。覽海醫療、紫鑫藥業、通策醫療漲停封板；佐力藥業、歐普康視、昭衍新藥等大漲7%；片仔癀、藥明康德、康龍化成、英科醫療、邁瑞醫療、愛爾眼科等細分領域龍頭漲逾5%。
（來源：wind）
港口板塊跌幅居前，寧波港領跌5.45%；北部灣港、上港集團、連雲港下跌4%左右；青島港、保税科技、日照港等個股紛紛跟跌。
（來源：wind）
能源設備板塊大跌，惠博普跌停，準油股份大跌9%；海默科技、恆泰艾普、通源石油、傑瑞股份跌逾5%。
（來源：wind）
科創板方面，傳音控股、恆玄科技、艾力斯-U漲逾7%，極米科技、奇安信-U等跟漲；而深科達、金盤科技領跌，跌超16%，華鋭精密、普門科技、光雲科技等均跌逾6%。
（來源：wind）
（來源：wind）
北向資金今日合計淨買入52.25億元，其中滬股通淨流入39.89億元，深股通淨流入12.36億元。
（來源：wind）
國盛證券認為，春節後的急速調整，只是抱團股價值趨向合理的正常走勢，財政積極貨幣穩健宏觀流動性並未全面收緊，場內槓桿率也並未處於異常水平，A股當前並不存在系統性風險，指數短線跌速快跌幅大，已出現情緒化特徵，目前建議按兵不動。
國金證券表示，重點關注中盤股投資機會。全球經濟復甦下，一方面滬深300等大盤成分股業績增長優勢不強，中盤股的成分股成長性更強；另一方面流動性收緊、利率上行的背景下，部分高估值的大盤股估值調整壓力較大，中證500、中證1000等中盤指數安全邊際凸顯。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app！
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
